Table 5.
Bayesian analysis provides evidence of nonreplication
GENESNP | Test hypothesis | Subsample | BF01 | Robustness |
---|---|---|---|---|
FOXP2rs6980093 | Any effect of genotype group, e.g. AA>AG>GG | MOUS visual | 2.96 | Weak |
MOUS auditory | 4.45 | Substantial | ||
EvLab visual | 17.21 | Strong | ||
AA>AG | MOUS visual | 4.87 | Substantial | |
MOUS auditory | 1.48 | Weak | ||
EvLab visual | 4.60 | Substantial | ||
AG>GG | MOUS visual | 8.54 | Substantial | |
MOUS auditory | 6.61 | Substantial | ||
EvLab visual | 6.52 | Substantial | ||
AA>GG | MOUS visual | 7.52 | Substantial | |
MOUS auditory | 3.84 | Substantial | ||
EvLab visual | 5.18 | Substantial | ||
FOXP2rs7784315 | TC>TT | MOUS visual | 4.41 | Substantial |
EvLab visual | 7.14 | Substantial | ||
KIAA0319…rs17243157 | CC>TC | MOUS visual | 2.42 | Weak |
MOUS auditory | 6.74 | Substantial | ||
EvLab visual | 6.40 | Substantial |
H1 hypotheses were based directly on the key findings of the Pinel et al. (2012) study, as detailed in main text (see also Figure 1). Bayes factors (reported as BF01) are shown for the results of testing these hypotheses against H0 (no replication of the original study) using Bayesian univariate ANOVA (rs6980093) or Bayesian independent-samples t test (rs7784315, rs17243157). BF01 > 10 indicates strong evidence and 10 > BF01 > 3 indicates substantial evidence for a nonreplication (see Materials and Methods).